Benzinga | Mar 16, 2021 04:21PM EDT

AVEO Pharmaceuticals Q4 EPS $(0.44) Down From $(0.28) YoY, Sales $886.00K Up From $764.00K YoY

AVEO Pharmaceuticals (NASDAQ:AVEO) reported quarterly losses of $(0.44) per share. This is a 57.14 percent decrease over losses of $(0.28) per share from the same period last year. The company reported $886.00 thousand in sales this quarter. This is a 15.97 percent increase over sales of $764.00 thousand the same period last year.